Alabama Incident of Contaminated IV Solution Appeals for USP 797 Compliance and Implementation

(prHWY.com) April 12, 2011 - Singapore, Singapore -- Nine out of nineteen patients died in this incident and the case is now handled by the investigators determined to identify if the infection from bacterium discovered inside the IV bags of TPN is the cause of the sudden death of the patients.

USP 797 is a regulation developed by U.S. Pharmacopoeia. It is designed to reduce infections transmitted to the patient through pharmaceutical products as well as to strengthen the safety and protection of people working in pharmacies as they are exposed to pharmaceuticals.

The intent of USP 797 is to set forth the procedural and practical requirements for safe compounding of sterile preparations. The Chapter's requirements are applicable in all practice settings where sterile preparations are compounded

Esco Isoclean Pharmacy Compounding Aseptic Isolator provides a safe and clean environment for compounding of non-hazardous, sterile drug preparations and IV admixtures in compliance with USP 797 criteria.

Barrier isolation system provides inherently superior sterility compared to open fronted clean air devices such as laminar flow clean benches and Class II biological safety cabinets. USP 797 guidelines specify that isolators may be situated in an area subject to less severe environmental controls compared with open fronted clean air devices.

Esco is ready to support personnel and facilities that prepares compounded sterile preparations (CSP) trying to comply with the standards set forth by USP 797 regulation. Esco's Vision is to provide enabling technologies for scientific discoveries to make human lives healthier and safer. Visit Esco Micro for more info.

###